Pitrazepin: Interactions with transmitter receptors of the central and peripheral nervous systems

CNS Drug Reviews

Volumn 6, Issue 4, 2000, Pages 290-302

  Demuro, Angelo ^a   Miledi, Ricardo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotics; GABAA receptors; Glycine receptors; N aryl piperazines; Nicotinic acetylcholine receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACETYLCHOLINE; BICUCULLINE; CLOZAPINE; DIAZEPAM; GLYCINE RECEPTOR; HETEROCYCLIC COMPOUND; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; PIPERAZINE DERIVATIVE; PITRAZEPIN; STRYCHNINE;

ANIMAL CELL; ANIMAL TISSUE; ANTICHOLINERGIC EFFECT; CENTRAL NERVOUS SYSTEM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GABAERGIC TRANSMISSION; MOUSE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RAT; REVIEW;

EID: 0034443012     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2000.tb00154.x     Document Type: Review

References (48)

1. Andreasen NC, Flaum M, Swayze VW, et al. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry 1990;47:615-621.
2. Aprison MH, Lipkowitz KB, Simon JR. Identification of a glycine-like fragment on the strychnine molecule. J Neurosci Res 1987;17:209-213.
3. Aprison MH, Galvez-Ruano E, Robertson DH, Lipkowitz KB. Glycine and GABA receptors: Molecular mechanisms controlling chloride ion flux. J Neurosci Res 1996;43:372-381.
4. Bakshi VP, Swerdlow NR, Geyer MA. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 1994;271:787-794.
5. Bakshi VP, Geyer MA. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther 1997;283:666-674.
6. Braestrup C, Nielsen M. Interaction of pitrazepin with the GABA/benzodiazepine receptor complex and with glycine receptors. Eur J Pharmacol 1985;118:115-121.
7. Claghorn J, Honigfeld G, Abuzzahab FS Sr, et al. The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987;7:377-384.
8. Cooper SJ, Leahey W, Liddle J, King DJ. The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia. Schizophr Res 1990;3:261-267.
9. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976;192:481-483.
10. Crow TJ. Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980;280:66-68.
11. Curtis DR, Duggan AW, Felix D, Johnston GA. Bicuculline and central GABA receptors. Nature 1970;228:676-677.
12. Curtis DR, Duggan AW, Felix D, Johnston GA. GABA, bicuculline and central inhibition. Nature 1970;226:1222-12224.
13. Curtis DR. Johnston GA. Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol 1974;69:97-188.
14. Curtis DR, Gynther BD. Pitrazepin: A central glycine and GABA antagonist. Eur J Pharmacol 1986;131:311-313.
15. Davis JM, Casper R. Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs 1977;14:260-282.
16. Demuro A, Martinez-Torres A, Francesconi W, Miledi R. Antagonistic action of pitrazepin on human and rat GABA(A) receptors. Br J Pharmacol 1999;127:57-64.
17. A receptor desensitization: The role of the gamma 2 subunit and its physiological significance. J Physiol 1996;497:145-159.
18. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 1989;99:S28-31.
19. Fitton A, Heel RC. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs 1990;40:722-747.
20. Fritschy JM, Benke D, Mertens S, et al. Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc Natl Acad Sci USA 1992;89:6726-6730.
21. A antagonist. Neurosci Lett 1984;45:311-316.
22. + current in voltage-clamped CA3 pyramidal cells in hippocampal cultures. Proc Natl Acad Sci USA 1985;82:1558-1562.
23. Galvez-Ruano E, Aprison MH, Robertson DH, Lipkowitz KB. Identifying agonistic and antagonistic mechanisms operative at the GABA receptor. J Neurosci Res 1995;42:666-673.
24. Galvez-Ruano E, Lipkowitz KB, Aprison MH. On identifying a second molecular antagonistic mechanism operative at the glycine receptor. J Neurosci Res 1995;41:775-781.
25. A-receptor subtypes: Differential association of the alpha-1 and alpha-3 subunits with serotonergic and GABAergic neurons. Neuroscience 1993;54:881-892.
26. Garcia-Colunga J, Miledi R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc Natl Acad Sci USA 1999;96:4113-4118.
27. Gundersen CB, Miledi R, Parker I. Messenger RNA from human brain induces drug-and voltage-operated channels in Xenopus oocytes. Nature 1984;308:421-424.
28. Hamill OP, Bormann J, Sakmann B. Activation of multiple-conductance state chloride channels in spinal neurones by glycine and GABA. Nature 1983;305:805-808.
29. Helmchen H. Clinical experience with clozapine in Germany. Psychopharmacology (Berl) 1989;99(Suppl):S80-3.
30. Hussain S, Bagust J, Gardner CR, et al. Quantitative analysis of gamma-aminobutyric acid (GABA) receptors of Purkinje cell layer from rat cerebellar slices. Gen Pharmacol 1990;21:355-364.
31. Kane JM, Honigfeld G, Singer J, Meltzer H. Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 1988;24:62-67.
32. Kemp JA, Marshall GR, Woodruff GN. Quantitative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation. Br J Pharmacol 1986;87:677-684.
33. Kim KH, Takeuchi H. Pharmacological characteristics of two different types of inhibitory GABA receptors on Achatina fulica neurones. Eur J Pharmacol 1990;182:49-62.
34. A receptors. Neuropharmacology 1996;35:1289-1298.
35. Miledi R, Parker I, Sumikawa K. Synthesis of chick brain GABA receptors by frog oocytes. Proc R Soc Lond B Biol Sci 1982;216:509-515.
36. Murphy VF, Wann KT. The action of GABA receptor agonists and antagonists on muscle membrane conductance in Schistocerca gregaria. Br J Pharmacol 1988;95:713-722.
37. Palma E, Fucile S, Barabino B, et al. Strychnine activates neuronal alpha, nicotinic receptors after mutations in the leucine ring and transmitter binding site domains. Proc Natl Acad Sci USA 1999;96:13421-13426.
38. A receptor antagonists. J Med Chem 1992;35:1969-1977.
39. Sattelle DB, Pinnock RD, Wafford KA, David JA. GABA receptors on the cell-body membrane of an identified insect motor neuron. Proc R Soc Lond B Biol Sci 1988;232:443-456.
40. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976;261:717-719.
41. A receptors are differentially sensitive to zinc: Dependence on subunit composition. Br J Pharmacol 1991;103:1837-1839.
42. 35S]TBPS binding. Brain Res 1987;414:357-364.
43. A receptor blockers: Implications for psychiatry. Neurochem Res 1993;18:787-793.
44. A receptors. Neurochem Res 1997;22:151-162.
45. Takeuchi H, Araki Y, Emaduddin M, et al. Identifiable Achatina giant neurones: Their localizations in ganglia, axonal pathways and pharmacological features. Gen Pharmacol 1996;27:3-32.
46. Whiting PJ, Bonnert TP, McKernan RM, et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann NY Acad Sci 1999;868:645-653.
47. Yongsiri A, Funase K, Takeuchi H, et al. Classification of GABA receptors in snail neurones. Eur J Pharmacol 1988;155:239-245.
48. Zhang W, Han XY, Wong SM, Takeuchi H. Pharmacologic characteristics of excitatory gamma-amino-butyric acid (GABA) receptors in a snail neuron. Gen Pharmacol 1997;28:45-53.